Drug
Interferon Beta 1A Plus Methylprednisolone
Interferon Beta 1A Plus Methylprednisolone: highest development phase Post-Market, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Interferon-beta-1a (Avonex) plus methylprednisolone NCT00168766 | Post-Market | Relapsing-remitting Multiple Sclerosis |
Latest
No recent events.
Follow Interferon Beta 1A Plus Methylprednisolone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.